Leo pharma unveils late-breaking data for landmark delta 3 open-label extension trial at the 2024 aad annual meeting

Madison, n.j.--(business wire)--leo pharma unveils late-breaking data for landmark delta 3 open-label extension trial at the 2024 aad annual meeting.

DAL Ratings Summary

DAL Quant Ranking